99 related articles for article (PubMed ID: 17150908)
21. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro].
Gao LL; Wu BY; Wang MW; Zhan DW; Zhang L; You WD; Wang WH
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):84-8. PubMed ID: 17645837
[TBL] [Abstract][Full Text] [Related]
22. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
23. Designing and utilization of siRNAs targeting RNA binding proteins.
Kim DH; Behlke M; Rossi JJ
Methods Mol Biol; 2008; 488():367-81. PubMed ID: 18982303
[TBL] [Abstract][Full Text] [Related]
24. A structure-activity relationship study of siRNAs with structural variations.
Chang CI; Hong SW; Kim S; Lee DK
Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
[TBL] [Abstract][Full Text] [Related]
25. [Effect of CRE-dependent RNA interference targeting Notch1 on proliferation of cervical cancer cell line HeLa].
Yu H; Huang SL; Zhao XP; Lu J; Qian GX; Ge SF
Ai Zheng; 2007 Feb; 26(2):148-53. PubMed ID: 17298743
[TBL] [Abstract][Full Text] [Related]
26. [siRNA knocks down the expression of AR gene in PC3 cell lines].
Chen W; Yu B; Xie D; Chen LW; Luo JH; Lu J; Dai YP; Zheng KL; Mei H
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):780-3. PubMed ID: 17929551
[TBL] [Abstract][Full Text] [Related]
27. RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: A preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases.
Diaz-Font A; Chabás A; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2006; 37(3):197-203. PubMed ID: 16959503
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure, and biological activity of dumbbell-shaped nanocircular RNAs for RNA interference.
Abe N; Abe H; Nagai C; Harada M; Hatakeyama H; Harashima H; Ohshiro T; Nishihara M; Furukawa K; Maeda M; Tsuneda S; Ito Y
Bioconjug Chem; 2011 Oct; 22(10):2082-92. PubMed ID: 21899349
[TBL] [Abstract][Full Text] [Related]
29. Specific knock-down of GAD67 in the striatum using naked small interfering RNAs.
Manrique C; Compan V; Rosselet C; Duflo SG
J Biotechnol; 2009 Jul; 142(3-4):185-92. PubMed ID: 19497341
[TBL] [Abstract][Full Text] [Related]
30. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
31. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
32. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
33. Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.
Wu Z; Gao Y; Sun L; Tien P; Jin Q
Antiviral Res; 2008 Dec; 80(3):295-301. PubMed ID: 18662724
[TBL] [Abstract][Full Text] [Related]
34. RNA interference: implications for cancer treatment.
Masiero M; Nardo G; Indraccolo S; Favaro E
Mol Aspects Med; 2007 Feb; 28(1):143-66. PubMed ID: 17307250
[TBL] [Abstract][Full Text] [Related]
35. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
[TBL] [Abstract][Full Text] [Related]
36. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 2'-O-modified adenosine building blocks and application for RNA interference.
Odadzic D; Bramsen JB; Smicius R; Bus C; Kjems J; Engels JW
Bioorg Med Chem; 2008 Jan; 16(1):518-29. PubMed ID: 17904849
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.
Sabbioni S; Callegari E; Spizzo R; Veronese A; Altavilla G; Corallini A; Negrini M
Cancer Gene Ther; 2007 Mar; 14(3):297-305. PubMed ID: 17218949
[TBL] [Abstract][Full Text] [Related]
39. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
40. Effective inhibition of infectious bursal disease virus replication in vitro by DNA vector-based RNA interference.
Gao Y; Liu W; Gao H; Qi X; Lin H; Wang X; Shen R
Antiviral Res; 2008 Aug; 79(2):87-94. PubMed ID: 18378010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
